以继发性高血压为首要表现的肢端肥大症1例

李东戈, 江荣炎, 涂胜, 等. 以继发性高血压为首要表现的肢端肥大症1例[J]. 临床心血管病杂志, 2024, 40(8): 692-694. doi: 10.13201/j.issn.1001-1439.2024.08.017
引用本文: 李东戈, 江荣炎, 涂胜, 等. 以继发性高血压为首要表现的肢端肥大症1例[J]. 临床心血管病杂志, 2024, 40(8): 692-694. doi: 10.13201/j.issn.1001-1439.2024.08.017
LI Dongge, JIANG Rongyan, TU Sheng, et al. One case of acromegaly first diagnosed due to secondary hypertension[J]. J Clin Cardiol, 2024, 40(8): 692-694. doi: 10.13201/j.issn.1001-1439.2024.08.017
Citation: LI Dongge, JIANG Rongyan, TU Sheng, et al. One case of acromegaly first diagnosed due to secondary hypertension[J]. J Clin Cardiol, 2024, 40(8): 692-694. doi: 10.13201/j.issn.1001-1439.2024.08.017

以继发性高血压为首要表现的肢端肥大症1例

  • 基金项目:
    安徽高校自然科学研究重点项目(No:KJ2020A0336);亳州市2021年重点研发计划(No:bzzc2021050;bzzc2021053)
详细信息

One case of acromegaly first diagnosed due to secondary hypertension

More Information
  • 肢端肥大症是一种起病隐匿的慢性进展性内分泌疾病,可并发各种严重的心血管疾病。我科收治1例以继发性高血压为首要表现的肢端肥大症患者,现报告如下。
  • 加载中
  • 图 1  患者面部和手部照片

    Figure 1.  Photos of the patient's face and hands

    图 2  葡萄糖生长激素抑制试验

    Figure 2.  Glucose growth hormone inhibition test

    图 3  患者心脏彩超及彩色多普勒

    Figure 3.  Heart color ultrasound and color Doppler

    图 4  患者头颅鞍区增强MRI

    Figure 4.  Enhanced MRI in the cranial saddle area of the patient

    图 5  组织病理检查

    Figure 5.  Histopathological examination

  • [1]

    Kasuki L, Rocha PDS, Lamback EB, et al. Determinants of morbidities and mortality in acromegaly[J]. Arch Endocrinol Metab, 2019, 63(6): 630-637. doi: 10.20945/2359-3997000000193

    [2]

    Puglisi S, Terzolo M. Hypertension and acromegaly[J]. Endocrinol Metab Clin North Am, 2019, 48: 779-793. doi: 10.1016/j.ecl.2019.08.008

    [3]

    谭惠文, 覃萌, 余叶蓉, 等. 肢端肥大症诊断和药物治疗进展—2021年《垂体协会肢端肥大症诊治指南更新》解读[J]. 中国全科医学, 2021, 24(27): 3397-3403. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202127002.htm

    [4]

    周沫, 陈月, 钱文杰, 等. 肢端肥大症患者心血管疾病风险血清标志物的变化及长效奥曲肽治疗对其水平的影响[J]. 解放军医学杂志, 2022, 47(1): 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202201010.htm

    [5]

    Giustina A, Barkhoudarian G, Beckers A, et al. Multidisciplinary management of acromegaly: A consensus[J]. Rev Endocr Metab Disord, 2020, 21(4): 667-678. doi: 10.1007/s11154-020-09588-z

    [6]

    Fleseriu M, Langlois F, Lim DST, et al. Acromegaly: pathogenesis, diagnosis, and management[J]. Lancet Diabetes Endocrinol, 2022, 10(11): 804-826. doi: 10.1016/S2213-8587(22)00244-3

    [7]

    Giustina A, Barkan A, Beckers A, et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update[J]. J Clin Endocrinol Metab, 2020, 105(4): dgz096.

    [8]

    Cadena-Obando DA, Remba-Shapiro I, Abreu-Rosario CG, et al. Acromegaly and it's cardiovascular implications[J]. Rev Med Inst Mex Seguro Soc, 2021, 59(1): 73-80.

    [9]

    Kamenicky P, Maione L, Chanson P. Cardiovascular complications of acromegaly[J]. Ann Endocrinol(Paris), 2021, 82(3-4): 206-209. doi: 10.1016/j.ando.2020.03.010

    [10]

    Hong S, Kim KS, Han K, et al. Acromegaly and cardiovascular outcomes: a cohort study[J]. Eur Heart J, 2022, 43(15): 1491-1499. doi: 10.1093/eurheartj/ehab822

    [11]

    Giantini-Larsen AM, Uribe-Cardenas R, Juthani RG. Acromegaly: medical and surgical considerations[J]. Otolaryngol Clin North Am, 2022, 55(2): 331-341. doi: 10.1016/j.otc.2021.12.007

    [12]

    Lim DST, Fleseriu M. Personalized medical treatment of patients with acromegaly: a review[J]. Endocr Pract, 2022, 28(3): 321-332. doi: 10.1016/j.eprac.2021.12.017

    [13]

    赵力博, 徐伟豪, 钱小顺, 等. 阻塞性睡眠呼吸暂停相关高血压的研究进展[J]. 解放军医学院学报, 2021, 42(4): 451-455. https://www.cnki.com.cn/Article/CJFDTOTAL-JYJX202104017.htm

  • 加载中

(5)

计量
  • 文章访问数:  776
  • PDF下载数:  394
  • 施引文献:  0
出版历程
收稿日期:  2023-08-03
刊出日期:  2024-08-13

目录